| Stage | UPBD | % of rev | GIII | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $1.1B | 100.00% | $554M | 100.00% | UPBD ×2.07 |
| Gross profit | $580M | 50.62% | $250M | 45.19% | UPBD +5.4pp |
| Operating income | $71M | 6.21% | $11M | 1.95% | UPBD +4.3pp |
| Pre-tax income | $47M | 4.08% | $14M | 2.54% | UPBD +1.5pp |
| Net income | $34M | 2.99% | $20M | 3.65% | GIII +0.7pp |
| Stage | UPBD | GIII | Gap · A − B |
|---|---|---|---|
| Revenue | $1.1B100.00% | $554M100.00% | UPBD ×2.07 |
| Gross profit | 50.62%$580M | 45.19%$250M | UPBD +5.4pp |
| Operating income | 6.21%$71M | 1.95%$11M | UPBD +4.3pp |
| Pre-tax income | 4.08%$47M | 2.54%$14M | UPBD +1.5pp |
| Net income |
| 2.99%$34M |
| 3.65%$20M |
| GIII +0.7pp |
No shared counterparties.